In comparison to nonsurgical treatment, balloon kyphoplasty: Improved standard of living; Reduced back discomfort and disability; and Did not increase adverse events like the threat of vertebral fracture over two years. ‘I have already been using balloon kyphoplasty to treat patients with unpleasant vertebral compression fractures for a long time so the instant and sustained pain relief we noticed in the study did not surprise me,’ concluded Jan Van Meirhaeghe, MD, research co-author and orthopaedic cosmetic surgeon, Division of Orthopaedic Surgery, St-Jans Hospital, Brugge, Belgium and Gent University Hospital, Gent, Belgium.Government’s Qualifying Therapeutic Discovery Task program. Proceeds from the grant will be used to support clinical trials for 22nd Century’s prescription product candidate, X-22, a smoking cigarettes cessation kit containing very low nicotine smokes made from the business’s proprietary tobacco, which includes 95 percent less nicotine compared to tobacco in existing ‘light’ smoking cigarettes. ‘The QTDP grant provides acknowledgement of 22nd Century’s novel and promising method of the large unmet medical dependence on cigarette smoking cessation therapies,’ stated Dr. Michael Moynihan, Vice President of Analysis and Development. Independent studies, including stage II clinical trials, possess demonstrated that VLN smoking cigarettes created from 22nd Century’s proprietary tobacco facilitate giving up by satisfying smokers’ cravings for cigarettes while greatly reducing nicotine exposure and nicotine dependence, and extinguishing the association between your act of smoking and the quick delivery of nicotine.